The CONSORT 2010 Statement provides updated, evidence-based guidelines to improve the reporting quality of parallel-group randomized controlled trials.
Enhances clinicians' assessment of parallel-group RCT validity; extends prior CONSORT statements with new methodological evidence.
The CONSORT statement is used worldwide to improve the reporting of randomised controlled trials. Kenneth Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience. To encourage dissemination of the CONSORT 2010 Statement, this article is freely accessible on bmj.com and will also be published in the Lancet, Obstetrics and Gynecology, PLoS Medicine, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.
No takes yet. Share an insight, caveat, or question.
KF Schulz (2010) studied Reporting of randomised controlled trials. CONSORT 2010 Statement was evaluated. The CONSORT 2010 Statement provides updated guidelines for the reporting of parallel group randomised trials based on new methodological evidence and accumulating experience.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: